We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Antigenics Inc. today announced that the Sabin Vaccine Institute has awarded the company's chairman and CEO, Garo H. Armen, PhD, the 2006 Sabin Humanitarian Award.
Imagenetix, Inc. today announced that, for the fiscal year ended March 31, 2006, it reported revenue of $7,649,941, a 1 percent increase on revenue of $7,574,194 in fiscal 2005.
Manhattan Pharmaceuticals, Inc. today announced that it commenced dosing the first group of patients in its Phase IIa clinical trial of oral Oleoyl-estrone (OE), the company's novel drug candidate for the treatment of obesity.
Avanir Pharmaceuticals announced that the FDA has informed the company it is extending the review period of its new drug application (NDA) for Neurodex for an additional 90 days.
Schering-Plough will establish Schering-Plough Produtos Farmaceuticos Limitada, a wholly owned operation based in Sao Paulo, Brazil, to market its core products, and will restructure its agreement with Brazilian drugmaker Mantefarma as part of its effort to increase its presence in Latin America, the company announced.
The FDA is focusing on improved use of epidemiological data and assessment of risk management plans (RMP) as two of the touchstones of its ongoing Prescription Drug User Fee Act (PDUFA) negotiations, a high-ranking agency official said.